Last reviewed · How we verify

NCT04611828

Slow-wave Enhancement in Adults Aged 30-49

Completed NA Last updated 28 January 2021
What this trial tests

NA trial testing Philips SmartSleep in Sleep in 28 participants. Completed in 4 December 2020.

Timeline
16 September 2019
Primary endpoint
4 December 2020
4 December 2020

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment28
Start date16 September 2019
Primary completion4 December 2020
Estimated completion4 December 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

Adults 30 to 49, any sex, with Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single-site, randomized study to assess the effectiveness of different types of closed-loop auditory stimulation on slow-wave enhancement using SmartSleep in an astronaut-like sample of adults between the ages of 30 and 55. Secondary analyses will be performed to determine whether slow-wave enhancement influences neurobehavioral performance in this population. Participants will be on study for 8 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04611828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing